NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Cumberland Pharmaceuticals Inc (NASDAQ: CPIX)
CPIX Technical Analysis
5
As on 24th Dec 2024 CPIX STOCK Price closed @ 2.51 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.79 & Strong Buy for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CPIXSTOCK Price
Open | 2.23 | Change | Price | % |
High | 2.59 | 1 Day | 0.26 | 11.56 |
Low | 2.23 | 1 Week | 0.13 | 5.46 |
Close | 2.51 | 1 Month | 1.31 | 109.17 |
Volume | 169452 | 1 Year | 1.01 | 67.33 |
52 Week High 2.44 | 52 Week Low 1.06 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
LMDX | 0.02 | 0.00% |
LCID | 3.20 | 3.23% |
AVGR | 1.45 | 126.56% |
NVDA | 140.22 | 0.39% |
AKTS | 0.04 | 0.00% |
TNXP | 0.39 | -2.50% |
PONO | 1.72 | 2.38% |
TELL | 1.00 | 0.00% |
TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CPIX Daily Charts |
CPIX Intraday Charts |
Whats New @ Bazaartrend |
CPIX Free Analysis |
|
CPIX Important Levels Intraday
RESISTANCE | 3.20 |
RESISTANCE | 2.98 |
RESISTANCE | 2.84 |
RESISTANCE | 2.71 |
SUPPORT | 2.31 |
SUPPORT | 2.18 |
SUPPORT | 2.04 |
SUPPORT | 1.82 |
CPIX Forecast December 2024
4th UP Forecast | 3.97 |
3rd UP Forecast | 3.5 |
2nd UP Forecast | 3.21 |
1st UP Forecast | 2.92 |
1st DOWN Forecast | 2.1 |
2nd DOWN Forecast | 1.81 |
3rd DOWN Forecast | 1.52 |
4th DOWN Forecast | 1.05 |
CPIX Weekly Forecast
4th UP Forecast | 2.84 |
3rd UP Forecast | 2.73 |
2nd UP Forecast | 2.67 |
1st UP Forecast | 2.60 |
1st DOWN Forecast | 2.42 |
2nd DOWN Forecast | 2.35 |
3rd DOWN Forecast | 2.29 |
4th DOWN Forecast | 2.18 |
CPIX Forecast2024
4th UP Forecast | 6.38 |
3rd UP Forecast | 5.14 |
2nd UP Forecast | 4.37 |
1st UP Forecast | 3.61 |
1st DOWN Forecast | 1.41 |
2nd DOWN Forecast | 0.65 |
3rd DOWN Forecast | -0.12 |
4th DOWN Forecast | -1.36 |
Cumberland Pharmaceuticals Inc ( NASDAQ USA Symbol : CPIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CPIX Other Details
Segment | EQ | |
Market Capital | 39430940.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
CPIX Address
CPIX Latest News
CPIX Business Profile
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Address: 2525 West End Avenue, Nashville, TN, United States, 37203
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service